Peter Shamamian
- Oncology top 5%
- Surgery top 5%
- Immunology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Stuart G. MarcusPaolo MignattiHerman YeeJess D. SchwartzSara MoneaJason P. ShawDavid WhitingKenneth Eng
- Topics
- Protease and Inhibitor Mechanisms (12 papers)Gallbladder and Bile Duct Disorders (9 papers)Pancreatitis Pathology and Treatment (8 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Peter Shamamian
64 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 107
- Oncology 740
- Surgery 649
- Immunology 612
- Molecular Biology 542
- Pulmonary and Respiratory Medicine 417
Countries citing papers authored by Peter Shamamian
This map shows the geographic impact of Peter Shamamian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Shamamian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Shamamian more than expected).
Fields of papers citing papers by Peter Shamamian
This network shows the impact of papers produced by Peter Shamamian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Shamamian. The network helps show where Peter Shamamian may publish in the future.
Co-authorship network of co-authors of Peter Shamamian
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Shamamian. A scholar is included among the top collaborators of Peter Shamamian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Shamamian. Peter Shamamian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 7 | |
| 3 | 24 | |
| 4 | 8 | |
| 5 | 6 | |
| 6 | 31 | |
| 7 | 31 | |
| 8 | 30 | |
| 9 | 39 | |
| 10 | 14 | |
| 11 | 36 | |
| 12 | 8 | |
| 13 | 283 | |
| 14 | 37 | |
| 15 | 151 | |
| 16 | 26 | |
| 17 | 35 | |
| 18 | 39 | |
| 19 | 41 | |
| 20 | 97 |
About Peter Shamamian
Peter Shamamian is a scholar working on Internal Medicine, Cancer Research and Hematology, having authored 68 papers that have together received 2.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (12 papers), Gallbladder and Bile Duct Disorders (9 papers) and Pancreatitis Pathology and Treatment (8 papers). The work is most often cited by research in Immunology (612 citations), Oncology (740 citations) and Cancer Research (346 citations). Peter Shamamian has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Stuart G. Marcus, Paolo Mignatti, Herman Yee, Jess D. Schwartz, Sara Monea, Jason P. Shaw, David Whiting, Kenneth Eng, Michael Dobryansky and Henry Cohen. Their work appears in journals such as The Journal of Experimental Medicine, Nature reviews. Cancer and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.